Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01610284 |
|---|---|
| Brief Title: | Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor (BELLE-2) |
| First Submitted : | May 11, 2012 |
| First Submitted that Met QC Criteria : | June 1, 2012 |
| First Posted : | June 4, 2012 (Estimate) |
| Results First Submitted : | April 15, 2020 |
| Results First Submitted that Met QC Criteria : | June 3, 2020 |
| Results First Posted : | June 18, 2020 |
| Last Update Submitted that Met QC Criteria : | August 24, 2020 |
| Last Update Posted : | August 25, 2020 |